Physician profile
William E Batty
NPI 1447246434
$413.97
in general payments reported to CMS, 2019-2025
7 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.32 · 2021: $37.89 · 2022: $21.96 · 2023: $48.74 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $121.27 | 2019-2025 | Otezla, Repatha, Krystexxa |
| Novo Nordisk INC | $67.88 | 2021-2025 | |
| Pfizer INC. | $66.66 | 2025 | |
| Abbott Laboratories | $62.17 | 2025 | Freestyle Libre 3 |
| Abbvie INC. | $56.85 | 2022-2023 | Ubrelvy, Qulipta |
| Bayer Healthcare Pharmaceuticals INC. | $25.29 | 2025 | |
| Novartis Pharmaceuticals Corporation | $13.85 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Batty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.